MedTrace Logo

Effect of Foot Reflexology on Pain Associated With Mediastinal Chest Drain Removal

NCT05631522 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2022-11-30

No results posted yet for this study

Summary

Cardiovascular diseases (CVDs) remain the leading cause of death worldwide and significantly affect patient quality of life and socioeconomic status. The care of CVD patients in Egypt is very complex and sensitive because of the high incidence and high mortality rate. The burden of CVD and the high prevalence of CVD risk factors in Egypt are alarming.

Despite great evidence of adverse clinical impact, the pain remains infrequently assessed and poorly managed in ICU. Pain has serious physical and psychological effects which can impair patient recovery and discharge. Moreover, it does not allow the patients to collaborate appropriately during care-related procedures, such as mobilization and respiratory therapy.

Conditions

  • Foot Reflexology

Interventions

OTHER

foot reflexology

Warm-Up Phase: Pre-reflexology foot massage and all-over foot squeeze will be performed for two minutes. Mini-Reflexology Session: Specific reflexology will be performed with special attention to two important foot reflex areas that include: Diaphragm and Solar Plexus Reflex Areas are located in the distance between the upper and middle third of the sole. The Heart and Lung Reflex Areas are located below the chest of the foot. The heart pumps the oxygen-rich blood around the body

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-01
Primary Completion
2023-01-30
Completion
2023-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05631522 on ClinicalTrials.gov